https://scholars.lib.ntu.edu.tw/handle/123456789/496142
標題: | Clinical features of heart failure hospitalization in younger and elderly patients in Taiwan | 作者: | CHIN-HSIAO TSENG | 公開日期: | 2011 | 卷: | 41 | 期: | 6 | 起(迄)頁: | 597-604 | 來源出版物: | European Journal of Clinical Investigation | 摘要: | Background This study compared the comorbidities, drugs, expenses and in-hospital mortality between younger and elderly patients hospitalized with heart failure. Methods A random sample of 1000000 insurants of the National Health Insurance program of Taiwan in 2005 was used. Comparisons were made between younger (20-64years) and elderly (?65years) patients. Results Heart failure hospitalization was identified in 2692 patients. Ageing, female sex, diabetes, hypertension, chronic obstructive pulmonary disease, nephropathy, infection and ischaemic heart disease were significantly associated with heart failure hospitalization. The incidence was 88 and 2181 per 100000 population, in younger and elderly people, respectively. The most common comorbidity in the elderly was hypertension (38·3%), followed by infection (32·0%) and ischaemic heart disease (31·9%). In younger patients, hypertension (41·3%), diabetes (35·5%) and ischaemic heart disease (29·8%) were the most common comorbidity. Diuretics were the most common drugs for both the younger (74·4%) and the elderly (76·9%) patients, followed by angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers and aspirin. The length of stay was longer (17·1 vs. 11·0days, P<0·0001), total expense higher (105290·5 vs. 85473·6 New Taiwan Dollars, P<0·05) and in-hospital mortality higher (4·2% vs. 2·7%, P=0·0823) in the elderly. Length of stay, nephropathy, infection, ischaemic heart disease and peripheral arterial disease were associated with expenses. In-hospital mortality was associated with age, length of stay, cancer, infection and peripheral arterial disease. Conclusions The elderly have a 25-fold higher risk of heart failure hospitalization, longer length of in-hospital stay, higher total medical expense and higher in-hospital mortality. ? 2010 The Author. European Journal of Clinical Investigation ? 2010 Stichting European Society for Clinical Investigation Journal Foundation. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955629997&doi=10.1111%2fj.1365-2362.2010.02447.x&partnerID=40&md5=b3a8383f0614b03f9ff990b4e3368781 https://scholars.lib.ntu.edu.tw/handle/123456789/496142 |
ISSN: | 0014-2972 | DOI: | 10.1111/j.1365-2362.2010.02447.x | SDG/關鍵字: | acetylsalicylic acid; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; calcium channel blocking agent; clopidogrel; digoxin; dipeptidyl carboxypeptidase inhibitor; diuretic agent; warfarin; adult; aged; aging; article; chronic obstructive lung disease; clinical feature; comorbidity; diabetes mellitus; female; heart failure; hospitalization; human; hypertension; incidence; infection; ischemic heart disease; kidney disease; length of stay; major clinical study; male; mortality; national health insurance; peripheral occlusive artery disease; priority journal; sex difference; Taiwan; Adult; Age Factors; Aged; Aged, 80 and over; Comorbidity; Female; Heart Failure; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Sex Factors; Taiwan; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。